Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 40
Filter
1.
Sichuan Da Xue Xue Bao Yi Xue Ban ; 55(1): 47-52, 2024 Jan 20.
Article in Chinese | MEDLINE | ID: mdl-38322520

ABSTRACT

Objective: To investigate the mechanical responses of mitochondrial morphology to extracellular matrix stiffness in human mesenchymal stem cells (hMSCs) and the role of AMP-activated protein kinase (AMPK) in the regulation of mitochondrial mechanoresponses. Methods: Two polyacrylamide (PAAm) hydrogels, a soft one with a Young's modulus of 1 kPa and a stiff one of 20 kPa, were prepared by changing the monomer concentrations of acrylamide and bis-acrylamide. Then, hMSCs were cultured on the soft and stiff PAAm hydrogels and changes in mitochondrial morphology were observed using a laser confocal microscope. Western blot was performed to determine the expression and activation of AMPK, a protein associated with mitochondrial homeostasis. Furthermore, the activation of AMPK was regulated on the soft and stiff matrixes by AMPK activator A-769662 and the inhibitor Compound C, respectively, to observe the morphological changes of mitochondria. Results: The morphology of the mitochondria in hMSCs showed heterogeneity when there was a change in gel stiffness. On the 1 kPa soft matrix, 74% mitochondria exhibited a dense, elongated filamentous network structure, while on the 20 kPa stiff matrix, up to 63.3% mitochondria were fragmented or punctate and were sparsely distributed. Western blot results revealed that the phosphorylated AMPK (p-AMPK)/AMPK ratio on the stiff matrix was 1.6 times as high as that on the soft one. Immunofluorescence assay results revealed that the expression of p-AMPK was elevated on the hard matrix and showed nuclear localization, which indicated that the activation of intracellular AMPK increased continuously along with the increase in extracellular matrix stiffness. When the hMSCs on the soft matrix were treated with A-769662, an AMPK activator, the mitochondria transitioned from a filamentous network morphology to a fragmented morphology, with the ratio of filamentous network decreasing from 74% to 9.5%. Additionally, AMPK inhibition with Compound C promoted mitochondrial fusion on the stiff matrix and significantly reduced the generation of punctate mitochondria. Conclusion: Extracellular matrix stiffness regulates mitochondrial morphology in hMSCs through the activation of AMPK. Stiff matrix promotes the AMPK activation, resulting in mitochondrial fission and the subsequent fragmentation of mitochondria. The impact of matrix stiffness on mitochondrial morphology can be reversed by altering the level of AMPK phosphorylation.


Subject(s)
AMP-Activated Protein Kinases , Extracellular Matrix , Mesenchymal Stem Cells , Mitochondria , Humans , Acrylamides/analysis , Acrylamides/metabolism , AMP-Activated Protein Kinases/analysis , AMP-Activated Protein Kinases/metabolism , Biphenyl Compounds , Cells, Cultured , Extracellular Matrix/chemistry , Extracellular Matrix/metabolism , Hydrogels/analysis , Hydrogels/metabolism , Pyrones , Thiophenes
2.
Cardiovasc Diabetol ; 19(1): 159, 2020 09 30.
Article in English | MEDLINE | ID: mdl-32998746

ABSTRACT

BACKGROUND: Whereas selective sodium-glucose cotransporter 2 (SGLT2) inhibitors consistently showed cardiovascular protective effects in large outcome trials independent of the presence of type 2 diabetes mellitus (T2DM), the cardiovascular effects of dual SGLT1/2 inhibitors remain to be elucidated. Despite its clinical relevance, data are scarce regarding left ventricular (LV) SGLT1 expression in distinct heart failure (HF) pathologies. We aimed to characterize LV SGLT1 expression in human patients with end-stage HF, in context of the other two major glucose transporters: GLUT1 and GLUT4. METHODS: Control LV samples (Control, n = 9) were harvested from patients with preserved LV systolic function who went through mitral valve replacement. LV samples from HF patients undergoing heart transplantation (n = 71) were obtained according to the following etiological subgroups: hypertrophic cardiomyopathy (HCM, n = 7); idiopathic dilated cardiomyopathy (DCM, n = 12); ischemic heart disease without T2DM (IHD, n = 14), IHD with T2DM (IHD + T2DM, n = 11); and HF patients with cardiac resynchronization therapy (DCM:CRT, n = 9, IHD:CRT, n = 9 and IHD-T2DM:CRT, n = 9). We measured LV SGLT1, GLUT1 and GLUT4 gene expressions with qRT-PCR. The protein expression of SGLT1, and activating phosphorylation of AMP-activated protein kinase (AMPKα) and extracellular signal-regulated kinase 1/2 (ERK1/2) were quantified by western blotting. Immunohistochemical staining of SGLT1 was performed. RESULTS: Compared with controls, LV SGLT1 mRNA and protein expressions were significantly and comparably upregulated in HF patients with DCM, IHD and IHD + T2DM (all P < 0.05), but not in HCM. LV SGLT1 mRNA and protein expressions positively correlated with LVEDD and negatively correlated with EF (all P < 0.01). Whereas AMPKα phosphorylation was positively associated with SGLT1 protein expression, ERK1/2 phosphorylation showed a negative correlation (both P < 0.01). Immunohistochemical staining revealed that SGLT1 expression was predominantly confined to cardiomyocytes, and not fibrotic tissue. Overall, CRT was associated with reduction of LV SGLT1 expression, especially in patients with DCM. CONCLUSIONS: Myocardial LV SGLT1 is upregulated in patients with HF (except in those with HCM), correlates significantly with parameters of cardiac remodeling (LVEDD) and systolic function (EF), and is downregulated in DCM patients with CRT. The possible role of SGLT1 in LV remodeling needs to be elucidated.


Subject(s)
Heart Failure/metabolism , Myocardium/chemistry , Sodium-Glucose Transporter 1/analysis , AMP-Activated Protein Kinases/analysis , Adult , Aged , Case-Control Studies , Extracellular Signal-Regulated MAP Kinases/analysis , Female , Gene Expression Regulation , Glucose Transporter Type 1/analysis , Glucose Transporter Type 4/analysis , Heart Failure/genetics , Heart Failure/physiopathology , Heart Failure/therapy , Humans , Male , Middle Aged , Phosphorylation , Sodium-Glucose Transporter 1/genetics , Sodium-Glucose Transporter 2/analysis
3.
Int J Mol Sci ; 21(14)2020 Jul 15.
Article in English | MEDLINE | ID: mdl-32679729

ABSTRACT

Adenosine monophosphate-activated protein kinase (AMPK) is in charge of numerous catabolic and anabolic signaling pathways to sustain appropriate intracellular adenosine triphosphate levels in response to energetic and/or cellular stress. In addition to its conventional roles as an intracellular energy switch or fuel gauge, emerging research has shown that AMPK is also a redox sensor and modulator, playing pivotal roles in maintaining cardiovascular processes and inhibiting disease progression. Pharmacological reagents, including statins, metformin, berberine, polyphenol, and resveratrol, all of which are widely used therapeutics for cardiovascular disorders, appear to deliver their protective/therapeutic effects partially via AMPK signaling modulation. The functions of AMPK during health and disease are far from clear. Accumulating studies have demonstrated crosstalk between AMPK and mitochondria, such as AMPK regulation of mitochondrial homeostasis and mitochondrial dysfunction causing abnormal AMPK activity. In this review, we begin with the description of AMPK structure and regulation, and then focus on the recent advances toward understanding how mitochondrial dysfunction controls AMPK and how AMPK, as a central mediator of the cellular response to energetic stress, maintains mitochondrial homeostasis. Finally, we systemically review how dysfunctional AMPK contributes to the initiation and progression of cardiovascular diseases via the impact on mitochondrial function.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Cardiovascular Diseases/metabolism , Mitochondria/metabolism , AMP-Activated Protein Kinases/analysis , Adenosine Triphosphate/metabolism , Animals , Cardiovascular Diseases/pathology , Energy Metabolism , Humans , Mitochondria/pathology , Mitochondrial Turnover , Reactive Oxygen Species/metabolism
4.
Cell Mol Life Sci ; 76(1): 129-145, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30151693

ABSTRACT

As an analgesic and antipyretic drug, acetaminophen (APAP) is commonly used and known to be safe at therapeutic doses. In many countries, the overuse of APAP provokes acute liver injury and even liver failure. APAP-induced liver injury (AILI) is the most used experimental model of drug-induced liver injury (DILI). Here, we have demonstrated elevated levels of growth arrest and DNA damage-inducible 45α (GADD45α) in the livers of patients with DILI/AILI, in APAP-injured mouse livers and in APAP-treated hepatocytes. GADD45α exhibited a protective effect against APAP-induced liver injury and alleviated the accumulation of small lipid droplets in vitro and in vivo. We found that GADD45α promoted the activation of AMP-activated protein kinase α and induced fatty acid beta-oxidation, tricarboxylic acid cycle (TCA) and glycogenolysis-related gene expression after APAP exposure. Liquid chromatography-mass spectrometry (LC-MS) analysis showed that GADD45α increased the levels of TCA cycle metabolites. Co-immunoprecipitation analysis showed that Ppp2cb, a catalytic subunit of protein phosphatase 2A, could interact directly with GADD45α. Our results indicate that hepatocyte GADD45α might represent a therapeutic target to prevent and rescue liver injury caused by APAP.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Acetaminophen/adverse effects , Antipyretics/adverse effects , Cell Cycle Proteins/metabolism , Chemical and Drug Induced Liver Injury/metabolism , Liver/drug effects , Nuclear Proteins/metabolism , AMP-Activated Protein Kinases/analysis , Analgesics, Non-Narcotic/adverse effects , Animals , Cell Cycle Proteins/analysis , Cells, Cultured , Chemical and Drug Induced Liver Injury/pathology , Citric Acid Cycle/drug effects , Enzyme Activation/drug effects , Fatty Acids/metabolism , Hepatocytes/drug effects , Hepatocytes/metabolism , Hepatocytes/pathology , Humans , Liver/metabolism , Liver/pathology , Male , Mice , Mice, Inbred C57BL , Nuclear Proteins/analysis , Signal Transduction/drug effects
5.
Mol Neurobiol ; 56(7): 5051-5066, 2019 Jul.
Article in English | MEDLINE | ID: mdl-30460617

ABSTRACT

In mammals, hypothalamic AMP-activated protein kinase (AMPK) α1 and α2 isoforms mainly relate to regulation of thermogenesis/liver metabolism and food intake, respectively. Since both isoforms are present in fish, which do not thermoregulate, we assessed their role(s) in hypothalamus regarding control of food intake and energy homeostasis. Since many fish species are carnivorous and mostly mammals are omnivorous, assessing if the role of hypothalamic AMPK is different is also an open question. Using the rainbow trout as a fish model, we first observed that food deprivation for 5 days did not significantly increase phosphorylation status of AMPKα in hypothalamus. Then, we administered adenoviral vectors that express dominant negative (DN) AMPKα1 or AMPKα2 isoforms. The inhibition of AMPKα2 (but not AMPKα1) led to decreased food intake. The central inhibition of AMPKα2 resulted in liver with decreased capacity of use and synthesis of glucose, lipids, and amino acids suggesting that a signal of nutrient abundance flows from hypothalamus to the liver, thus suggesting a role for central AMPKα2 in the regulation of peripheral metabolism in fishes. The central inhibition of AMPKα1 induced comparable changes in liver metabolism though at a lower extent. From an evolutionary point of view, it is of interest that the function of central AMPKα2 remained similar throughout the vertebrate lineage. In contrast, the function of central AMPKα1 in fish relates to modulation of liver metabolism whereas in mammals modulates not only liver metabolism but also brown adipose tissue and thermogenesis.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Evolution, Molecular , Hypothalamus/enzymology , AMP-Activated Protein Kinases/analysis , Animals , Hypothalamus/chemistry , Isoenzymes/analysis , Isoenzymes/metabolism , Oncorhynchus mykiss
6.
Acta Cir Bras ; 33(6): 533-541, 2018 Jun.
Article in English | MEDLINE | ID: mdl-30020315

ABSTRACT

PURPOSE: To investigate the specific molecular mechanisms and effects of curcumin derivative J147 on diabetic peripheral neuropathy (DPN). METHODS: We constructed streptozotocin (STZ)-induced DPN rat models to detected mechanical withdrawal threshold (MWT) in vivo using Von Frey filaments. In vitro, we measured cell viability and apoptosis, adenosine 5'-monophosphate-activated protein kinase (AMPK) and transient receptor potential A1 (TRPA1) expression using MTT, flow cytometry, qRT-PCR and western blot. Then, TRPA1 expression level and calcium reaction level were assessed in agonist AICAR treated RSC96cells. RESULTS: The results showed that J147reduced MWT in vivo, increased the mRNA and protein level of AMPK, reduced TRPA1 expression and calcium reaction level in AITCR treated RSC96 cells, and had no obvious effect on cell viability and apoptosis. Besides, AMPK negative regulated TRPA1 expression in RSC96 cells. CONCLUSIONS: J147 could ameliorate DPN via negative regulation AMPK on TRPA1 in vivo and in vitro. A curcumin derivative J147might be a new therapeutic potential for the treatment of DPN.


Subject(s)
AMP-Activated Protein Kinases/drug effects , Curcumin/analogs & derivatives , Curcumin/pharmacology , Diabetic Neuropathies/drug therapy , TRPA1 Cation Channel/drug effects , AMP-Activated Protein Kinases/analysis , Animals , Apoptosis/drug effects , Blotting, Western , Calcium/analysis , Cell Survival/drug effects , Cells, Cultured , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/metabolism , Diabetic Neuropathies/metabolism , Male , Microscopy, Fluorescence , Real-Time Polymerase Chain Reaction , Reproducibility of Results , Streptozocin , TRPA1 Cation Channel/analysis , Time Factors
7.
Acta cir. bras ; 33(6): 533-541, June 2018. graf
Article in English | LILACS | ID: biblio-949351

ABSTRACT

Abstract Purpose: To investigate the specific molecular mechanisms and effects of curcumin derivative J147 on diabetic peripheral neuropathy (DPN). Methods: We constructed streptozotocin (STZ)-induced DPN rat models to detected mechanical withdrawal threshold (MWT) in vivo using Von Frey filaments. In vitro, we measured cell viability and apoptosis, adenosine 5'-monophosphate-activated protein kinase (AMPK) and transient receptor potential A1 (TRPA1) expression using MTT, flow cytometry, qRT-PCR and western blot. Then, TRPA1 expression level and calcium reaction level were assessed in agonist AICAR treated RSC96cells. Results: The results showed that J147reduced MWT in vivo, increased the mRNA and protein level of AMPK, reduced TRPA1 expression and calcium reaction level in AITCR treated RSC96 cells, and had no obvious effect on cell viability and apoptosis. Besides, AMPK negative regulated TRPA1 expression in RSC96 cells. Conclusions: J147 could ameliorate DPN via negative regulation AMPK on TRPA1 in vivo and in vitro. A curcumin derivative J147might be a new therapeutic potential for the treatment of DPN.


Subject(s)
Animals , Male , Curcumin/analogs & derivatives , Curcumin/pharmacology , Diabetic Neuropathies/drug therapy , AMP-Activated Protein Kinases/drug effects , TRPA1 Cation Channel/drug effects , Time Factors , Cell Survival/drug effects , Cells, Cultured , Blotting, Western , Calcium/analysis , Reproducibility of Results , Apoptosis/drug effects , Streptozocin , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/metabolism , Diabetic Neuropathies/metabolism , AMP-Activated Protein Kinases/analysis , Real-Time Polymerase Chain Reaction , TRPA1 Cation Channel/analysis , Microscopy, Fluorescence
8.
Methods Mol Biol ; 1732: 433-448, 2018.
Article in English | MEDLINE | ID: mdl-29480491

ABSTRACT

Hypothalamic AMPK plays a key role in the control of energy homeostasis by regulating energy intake and energy expenditure, particularly modulating brown adipose tissue (BAT) thermogenesis. The function of AMPK can be assayed by analyzing its phosphorylated protein levels in tissues, since AMPK is activated when it is phosphorylated at Thr-172. Here, we describe a method to obtain hypothalamic (nuclei-specific) protein extracts and the suitable conditions to assay AMPK phosphorylation by Western blotting.


Subject(s)
AMP-Activated Protein Kinases/analysis , Enzyme Activation/drug effects , Enzyme Assays/methods , Hypothalamus/metabolism , Isoenzymes/metabolism , AMP-Activated Protein Kinases/genetics , AMP-Activated Protein Kinases/immunology , AMP-Activated Protein Kinases/metabolism , Adenoviridae/genetics , Animals , Antibodies, Phospho-Specific/immunology , Enzyme Activation/genetics , Enzyme Activators/pharmacology , Enzyme Assays/instrumentation , Enzyme Inhibitors/pharmacology , Genetic Vectors/genetics , Isoenzymes/genetics , Isoenzymes/immunology , Mice , Phosphorylation/drug effects , Phosphorylation/genetics , Phosphorylation/immunology , Rats , Stereotaxic Techniques/instrumentation , Threonine/immunology , Threonine/metabolism
9.
Life Sci ; 194: 98-103, 2018 Feb 01.
Article in English | MEDLINE | ID: mdl-29273527

ABSTRACT

AIMS: Sestrins, a class of stress-related proteins, is involved in the control of aging-induced organic dysfunctions and metabolic control. However, the factors that modulate the levels of Sestrins are poorly studied. Here, we evaluated the effects of acute and chronic aerobic exercise on Sestrin 1 (Sesn1) and Sesn2 protein contents in the skeletal muscle of mice. MAIN METHODS: Male C57BL/6J mice performed an acute or chronic (4weeks) exercise protocols on a treadmill running at 60% of the peak workload. Then, the quadriceps muscle was removed and analyzed by Western blot. Bioinformatics analysis was also performed to evaluate Sesn1 and Sesn2 mRNA in the skeletal muscle and phenotypic pattern in a large panel of isogenic strains of BXD mice. KEY FINDINGS: While acute aerobic exercise increased Sesn1 accumulation and induced a discrete augment of Sesn2 protein content and AMPK threonine phosphorylation, chronic exercise reduced the basal levels of Sesn1 and Sesn2 as well as of AMPK threonine phosphorylation in the quadriceps muscles of C57BL/6J mice. In accordance with these experimental approaches, transcriptomic analysis revealed that Sesn1 and Sesn2 mRNA levels in the skeletal muscle were inversely correlated with the locomotor activity in several strains of BXD mice. SIGNIFICANCE: Our data suggest that physical exercise has role on Sestrin1 and Sestrin2 expression on skeletal muscle, providing new insights into the mechanism by which physical exercise affects stress-related proteins in skeletal muscles.


Subject(s)
Cell Cycle Proteins/metabolism , Muscle, Skeletal/physiology , Nuclear Proteins/metabolism , AMP-Activated Protein Kinases/analysis , AMP-Activated Protein Kinases/metabolism , Animals , Cell Cycle Proteins/analysis , Male , Mice, Inbred C57BL , Nuclear Proteins/analysis , Peroxidases , Phosphorylation , Physical Conditioning, Animal , Running
10.
Elife ; 62017 12 14.
Article in English | MEDLINE | ID: mdl-29239720

ABSTRACT

Cells use multiple feedback controls to regulate metabolism in response to nutrient and signaling inputs. However, feedback creates the potential for unstable network responses. We examined how concentrations of key metabolites and signaling pathways interact to maintain homeostasis in proliferating human cells, using fluorescent reporters for AMPK activity, Akt activity, and cytosolic NADH/NAD+ redox. Across various conditions, including glycolytic or mitochondrial inhibition or cell proliferation, we observed distinct patterns of AMPK activity, including both stable adaptation and highly dynamic behaviors such as periodic oscillations and irregular fluctuations that indicate a failure to reach a steady state. Fluctuations in AMPK activity, Akt activity, and cytosolic NADH/NAD+ redox state were temporally linked in individual cells adapting to metabolic perturbations. By monitoring single-cell dynamics in each of these contexts, we identified PI3K/Akt regulation of glycolysis as a multifaceted modulator of single-cell metabolic dynamics that is required to maintain metabolic stability in proliferating cells.


Subject(s)
Energy Metabolism , Epithelial Cells/metabolism , Gene Expression Regulation , Glycolysis , Phosphatidylinositol 3-Kinases/analysis , Proto-Oncogene Proteins c-akt/analysis , AMP-Activated Protein Kinases/analysis , Cell Line , Cell Proliferation , Humans , NAD/analysis
11.
Sci Rep ; 7(1): 8982, 2017 08 21.
Article in English | MEDLINE | ID: mdl-28827681

ABSTRACT

Rodent models of maternal obesity have been associated with kidney damage and dysfunction in offspring. However, the underlying mechanisms are yet to be elucidated. In this study, female rats were fed a high-fat diet (HFD) for 6 weeks prior to mating, throughout gestation and lactation; both male and female offspring were examined at weaning. Our results demonstrate that renal lipid deposition was increased in male offspring only, which is associated with reduced protein expression of Sirtuin (SIRT) 1, an essential regulator of lipid metabolism and stress response. Other components in its signalling network including phosphorylated 5'-AMP-activated protein kinase (pAMPKα), Forkhead box FOXO3a and Peroxisome proliferator-activated receptor (PPAR)γ coactivator 1-alpha (PGC-1α) were also downregulated. By contrast, in female offspring, renal fat/lipid distribution was unchanged in coupling with normal SIRT1 regulation. Specific autophagy and antioxidant markers were suppressed in both sexes. On the other hand, fibronectin and Collagen type IV protein expression was significantly higher in the offspring born HFD-fed dams, particularly in the males. Collectively, these findings suggest that maternal HFD consumption can induce sex-specific changes in offspring kidney lipid metabolism and stress responses at early ages, which may underpin the risk of kidney diseases later in life.


Subject(s)
Diet, High-Fat , Intra-Abdominal Fat/pathology , Kidney/pathology , Obesity/pathology , Prenatal Exposure Delayed Effects , Sirtuin 1/analysis , Stress, Physiological , AMP-Activated Protein Kinases/analysis , Animals , Disease Models, Animal , Female , Forkhead Box Protein O3/analysis , Male , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha/analysis , Pregnancy , Rats , Sex Factors
12.
Mol Cell ; 67(4): 685-701.e6, 2017 Aug 17.
Article in English | MEDLINE | ID: mdl-28803777

ABSTRACT

Metabolic deregulation is a hallmark of human cancers, and the glycolytic and glutamine metabolism pathways were shown to be deregulated in pancreatic ductal adenocarcinoma (PDAC). To identify new metabolic regulators of PDAC tumor growth and metastasis, we systematically knocked down metabolic genes that were overexpressed in human PDAC tumor samples using short hairpin RNAs. We found that p53 transcriptionally represses paraoxonase 2 (PON2), which regulates GLUT1-mediated glucose transport via stomatin. The loss of PON2 initiates the cellular starvation response and activates AMP-activated protein kinase (AMPK). In turn, AMPK activates FOXO3A and its transcriptional target, PUMA, which induces anoikis to suppress PDAC tumor growth and metastasis. Pharmacological or genetic activation of AMPK, similar to PON2 inhibition, blocks PDAC tumor growth. Collectively, our results identify PON2 as a new modulator of glucose transport that regulates a pharmacologically tractable pathway necessary for PDAC tumor growth and metastasis.


Subject(s)
Aryldialkylphosphatase/metabolism , Carcinoma, Pancreatic Ductal/enzymology , Cell Movement , Cell Proliferation , Energy Metabolism , Glucose Transporter Type 1/metabolism , Liver Neoplasms/enzymology , Lung Neoplasms/enzymology , Pancreatic Neoplasms/enzymology , AMP-Activated Protein Kinases/analysis , AMP-Activated Protein Kinases/genetics , AMP-Activated Protein Kinases/metabolism , Animals , Antineoplastic Agents/pharmacology , Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/metabolism , Aryldialkylphosphatase/genetics , Carcinoma, Pancreatic Ductal/drug therapy , Carcinoma, Pancreatic Ductal/genetics , Carcinoma, Pancreatic Ductal/pathology , Cell Line, Tumor , Cell Movement/drug effects , Cell Proliferation/drug effects , Energy Metabolism/drug effects , Female , Forkhead Box Protein O3/genetics , Forkhead Box Protein O3/metabolism , Gene Expression Regulation, Neoplastic , Glucose/metabolism , Glucose Transporter Type 1/genetics , Humans , Liver Neoplasms/genetics , Liver Neoplasms/prevention & control , Liver Neoplasms/secondary , Lung Neoplasms/genetics , Lung Neoplasms/prevention & control , Lung Neoplasms/secondary , Male , Mice, Nude , Mutation , Pancreatic Neoplasms/drug therapy , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/pathology , Protein Kinase Inhibitors/pharmacology , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins p21(ras)/genetics , RNA Interference , Signal Transduction , Time Factors , Transcription, Genetic , Transfection , Tumor Burden , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism , Xenograft Model Antitumor Assays
13.
Methods Enzymol ; 587: 465-480, 2017.
Article in English | MEDLINE | ID: mdl-28253973

ABSTRACT

The AMP-activated protein kinase (AMPK) is a master regulator of metabolic homeostasis. It is activated by the upstream kinase LKB1 (liver kinase B1) when the AMP/ATP ratio is increased during starvation or heightened exercises. Based on reconstitution experiments using purified individual proteins, AMPK was demonstrated to be directly phosphorylated on its conserved residue Thr172 by LKB1, which was promoted by increased levels of AMP. However, recent studies have engendered a paradigm shift for how AMPK is activated inside the cell or animal tissues, unraveling that AXIN binds to LKB1 and tethers it to AMPK located on the surface of late endosome and lysosome (hereafter, only lysosome is discussed) in response to glucose starvation. Moreover, AXIN extends its interaction with the v-ATPase-Ragulator complex, which is paradoxically also required for activation of mTORC1 despite the fact that the two kinases AMPK and mTORC1 are inversely activated. Here, we summarize the experimental procedures of the assays for translocation of AXIN/LKB1 to the detergent-resistant lipid fractions of lysosomal membrane and the assembly of AMPK-activating complexes thereon. These methods will be useful for determining whether AMPK activation induced by various metabolic stresses or by pharmacological stimuli is mediated by the v-ATPase-Ragulator-AXIN/LKB1 axis.


Subject(s)
AMP-Activated Protein Kinases/analysis , AMP-Activated Protein Kinases/metabolism , Lysosomes/metabolism , Molecular Biology/methods , Acetyltransferases/genetics , Acetyltransferases/isolation & purification , Animals , Axin Protein/genetics , Axin Protein/metabolism , Cells, Cultured , Enzyme Activation , Glucose/metabolism , Immunoprecipitation/methods , Lysosomes/chemistry , Male , Mice, Inbred C57BL , Phosphorylation , Protein Serine-Threonine Kinases/metabolism
14.
Methods Enzymol ; 587: 481-509, 2017.
Article in English | MEDLINE | ID: mdl-28253974

ABSTRACT

AMP-activated protein kinase (AMPK) is a heterotrimeric serine/threonine protein kinase found in nearly all eukaryotes that functions as a master energy sensor in cells. During times of cell stress and changes in the AMP/ATP ratio, AMPK becomes activated and phosphorylates a multitude of protein substrates involved in various cellular processes such as metabolism, cell growth and autophagy. The endogenous ligand AMP is known to bind to the γ-subunit and activates the enzyme via three distinct mechanisms (1) enhancing phosphorylation by upstream kinases of Thr172 in the activation loop (a site critical for AMPK activity), (2) protecting Thr172 from dephosphorylation by phosphatases, and (3) allosteric activation of the kinase activity. Given the important regulatory role for AMPK in various cellular processes and the multiple known modes of activation, there is great interest in identifying small-molecule activators of this kinase and a need for assays to identify and characterize compounds. Here we describe several assay formats that have been used for identifying and characterizing small-molecule AMPK activators.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Molecular Biology/methods , AMP-Activated Protein Kinase Kinases , AMP-Activated Protein Kinases/analysis , AMP-Activated Protein Kinases/chemistry , Adenosine Triphosphate/metabolism , Allosteric Regulation , Animals , Enzyme Activation , Fluorescence Resonance Energy Transfer , Humans , Phosphorus Radioisotopes , Phosphorylation , Protein Phosphatase 2/metabolism , Protein Serine-Threonine Kinases/metabolism , Threonine/metabolism
15.
PLoS One ; 12(3): e0173074, 2017.
Article in English | MEDLINE | ID: mdl-28278224

ABSTRACT

SCOPE: Olive-tree polyphenols have demonstrated potential for the management of obesity-related pathologies. We aimed to explore the capacity of Olive-tree leaves extract to modulate triglyceride accumulation and AMP-activated protein kinase activity (AMPK) on a hypertrophic adipocyte model. METHODS: Intracellular triglycerides and AMPK activity were measured on the hypertrophic 3T3-L1 adipocyte model by AdipoRed and immunofluorescence microscopy, respectively. Reverse phase high performance liquid chromatography coupled to time-of-flight mass detection with electrospray ionization (RP-HPLC-ESI-TOF/MS) was used for the fractionation of the extract and the identification of the compounds. In-silico molecular docking of the AMPK alpha-2, beta and gamma subunits with the identified compounds was performed. RESULTS: Olive-tree leaves extract decreased the intracellular lipid accumulation through AMPK-dependent mechanisms in hypertrophic adipocytes. Secoiridoids, cinnamic acids, phenylethanoids and phenylpropanoids, flavonoids and lignans were the candidates predicted to account for this effect. Molecular docking revealed that some compounds may be AMPK-gamma modulators. The modulatory effects of compounds over the alpha and beta AMPK subunits appear to be less probable. CONCLUSIONS: Olive-tree leaves polyphenols modulate AMPK activity, which may become a therapeutic aid in the management of obesity-associated disturbances. The natural occurrence of these compounds may have important nutritional implications for the design of functional ingredients.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Gene Expression Regulation/drug effects , Olea/chemistry , Polyphenols/pharmacology , 3T3-L1 Cells , AMP-Activated Protein Kinases/analysis , AMP-Activated Protein Kinases/chemistry , Adipocytes/cytology , Adipocytes/drug effects , Adipocytes/metabolism , Animals , Binding Sites , Chromatography, High Pressure Liquid , Chromatography, Reverse-Phase , Mice , Microscopy, Fluorescence , Molecular Docking Simulation , Olea/metabolism , Plant Extracts/analysis , Plant Extracts/chemistry , Plant Leaves/chemistry , Plant Leaves/metabolism , Polyphenols/chemistry , Polyphenols/isolation & purification , Polyphenols/metabolism , Protein Structure, Tertiary , Protein Subunits/analysis , Protein Subunits/metabolism , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Triglycerides/analysis , Triglycerides/metabolism
16.
Biol Res ; 49(1): 38, 2016 Sep 07.
Article in English | MEDLINE | ID: mdl-27604997

ABSTRACT

BACKGROUND: From ancient times, marine algae have emerged as alternative medicine and foods, contains the rich source of natural products like proteins, vitamins, and secondary metabolites, especially Chlorella vulgaris (C. vulgaris) contains numerous anti-inflammatory, antioxidants and wound healing substances. Type 2 diabetes mellitus is closely associated with adipogenesis and their factors. Hence, we aimed to investigate the chemical constituents and adipogenic modulatory properties of C. vulgaris in 3T3-L1 pre-adipocytes. RESULTS: We analysed chemical constituents in ethanolic extract of C. vulgaris (EECV) by LC-MS. Results revealed that the EECV contains few triterpenoids and saponin compounds. Further, the effect of EECV on lipid accumulation along with genes and proteins expressions which are associated with adipogenesis and lipogenesis were evaluated using oil red O staining, qPCR and western blot techniques. The data indicated that that EECV treatment increased differentiation and lipid accumulation in 3T3-L1 cells, which indicates positive regulation of adipogenic and lipogenic activity. These increases were associated with up-regulation of PPAR-γ2, C/EBP-α, adiponectin, FAS, and leptin mRNA and protein expressions. Also, EECV treatments increased the concentration of glycerol releases as compared with control cells. Troglitazone is a PPAR-γ agonist that stimulates the PPAR-γ2, adiponectin, and GLUT-4 expressions. Similarly, EECV treatments significantly upregulated PPAR-γ2, adiponectin, GLUT-4 expressions and glucose utilization. Further, EECV treatment decreased AMPK-α expression as compared with control and metformin treated cells. CONCLUSION: The present research findings confirmed that the EECV effectively modulates the lipid accumulation and differentiation in 3T3-L1 cells through AMPK-α mediated signalling pathway.


Subject(s)
3T3-L1 Cells/drug effects , Chlorella vulgaris/chemistry , Plant Extracts/pharmacology , Seaweed/chemistry , 3T3-L1 Cells/physiology , AMP-Activated Protein Kinases/analysis , AMP-Activated Protein Kinases/drug effects , AMP-Activated Protein Kinases/metabolism , Adipocytes/cytology , Adipocytes/drug effects , Adipocytes/metabolism , Adiponectin/analysis , Adiponectin/metabolism , Animals , Cell Differentiation/drug effects , Cell Survival/drug effects , Cells, Cultured , Diabetes Mellitus, Type 2/metabolism , Down-Regulation , Gene Expression , Glucose/metabolism , Glucose Transporter Type 4/analysis , Glucose Transporter Type 4/drug effects , Glucose Transporter Type 4/metabolism , Mice , PPAR gamma/analysis , PPAR gamma/drug effects , PPAR gamma/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Time Factors , Up-Regulation
17.
Sci Rep ; 6: 30051, 2016 07 21.
Article in English | MEDLINE | ID: mdl-27444220

ABSTRACT

Energy metabolism, involving the ATP-dependent AMPK-PgC-Ppar pathway impacts metabolic health immensely, in that its impairment can lead to obesity, giving rise to disease. Based on observations that individuals with Gilbert's syndrome (GS; UGT1A1(*)28 promoter mutation) are generally lighter, leaner and healthier than controls, specific inter-group differences in the AMPK pathway regulation were explored. Therefore, a case-control study involving 120 fasted, healthy, age- and gender matched subjects with/without GS, was conducted. By utilising intra-cellular flow cytometry (next to assessing AMPKα1 gene expression), levels of functioning proteins (phospho-AMPK α1/α2, PgC 1 α, Ppar α and γ) were measured in PBMCs (peripheral blood mononucleated cells). In GS individuals, rates of phospho-AMPK α1/α2, -Ppar α/γ and of PgC 1α were significantly higher, attesting to a boosted fasting response in this condition. In line with this finding, AMPKα1 gene expression was equal between the groups, possibly stressing the post-translational importance of boosted fasting effects in GS. In reflection of an apparently improved health status, GS individuals had significantly lower BMI, glucose, insulin, C-peptide and triglyceride levels. Herewith, we propose a new theory to explain why individuals having GS are leaner and healthier, and are therefore less likely to contract metabolic diseases or die prematurely thereof.


Subject(s)
AMP-Activated Protein Kinases/analysis , Gilbert Disease/pathology , Leukocytes, Mononuclear/enzymology , Metabolic Networks and Pathways , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha/analysis , Peroxisome Proliferator-Activated Receptors/analysis , AMP-Activated Protein Kinases/genetics , Adolescent , Adult , Case-Control Studies , Female , Gene Expression Profiling , Humans , Male , Middle Aged , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha/genetics , Peroxisome Proliferator-Activated Receptors/genetics , Young Adult
18.
Anim Sci J ; 87(5): 718-28, 2016 May.
Article in English | MEDLINE | ID: mdl-26712455

ABSTRACT

Effects of water-misting sprays with forced ventilation on post mortem glycolysis, adenosine monophosphate-activated protein kinase (AMPK) and meat quality of broilers after transport during summer were investigated in the present paper. A total of 105 mixed-sex Arbor Acres broilers were divided into three treatment groups: (i) 45 min transport without rest (T); (ii) 45 min transport with 1 h rest (TR); and (iii) 45 min transport with 15 min water-misting sprays with forced ventilation and 45 min rest (TWFR). Each treatment consisted of five replicates with seven birds each. The results indicated that the water-misting sprays with forced ventilation could mitigate the stress caused by transport under high temperature conditions during summer, which reduced the energy depletion in post mortem Pectoralis major (PM) muscle. This resulted in a higher energy status compared to the T group, which would decrease the expression of phosphorylation of AMPK (p-AMPK). Furthermore, decreased the expression of p-AMPK then slowed down the rate of glycolysis in post mortem PM muscle during the early post mortem period, which in turn lessened the negative effects caused by transport on meat quality. In conclusion, water-misting sprays with forced ventilation may be a better method to control the incidence of the pale, soft and exudative meat in broilers.


Subject(s)
AMP-Activated Protein Kinases/analysis , Chickens , Food Analysis , Food Quality , Glycolysis , Hot Temperature , Meat , Postmortem Changes , Seasons , Transportation , Ventilation , Water/administration & dosage , AMP-Activated Protein Kinases/metabolism , Animals , Female , Male , Meat/analysis , Pectoralis Muscles/metabolism , Phosphorylation , Time Factors
19.
Biol. Res ; 49: 1-11, 2016. ilus, graf
Article in English | LILACS | ID: biblio-950864

ABSTRACT

BACKGROUND: From ancient times, marine algae have emerged as alternative medicine and foods, contains the rich source of natural products like proteins, vitamins, and secondary metabolites, especially Chlorella vulgaris (C. vulgaris) contains numerous anti-inflammatory, antioxidants and wound healing substances. Type 2 diabetes mellitus is closely associated with adipogenesis and their factors. Hence, we aimed to investigate the chemical constituents and adipo-genic modulatory properties of C. vulgaris in 3T3-L1 pre-adipocytes. RESULTS: We analysed chemical constituents in ethanolic extract of C. vulgaris (EECV) by LC-MS. Results revealed that the EECV contains few triterpenoids and saponin compounds. Further, the effect of EECV on lipid accumulation along with genes and proteins expressions which are associated with adipogenesis and lipogenesis were evaluated using oil red O staining, qPCR and western blot techniques. The data indicated that that EECV treatment increased differentiation and lipid accumulation in 3T3-L1 cells, which indicates positive regulation of adipogenic and lipogenic activity. These increases were associated with up-regulation of PPAR-γ2, C/EBP-α, adiponectin, FAS, and leptin mRNA and protein expressions. Also, EECV treatments increased the concentration of glycerol releases as compared with control cells. Troglitazone is a PPAR-γ agonist that stimulates the PPAR-y2, adiponectin, and GLUT-4 expressions. Similarly, EECV treatments significantly upregulated PPAR-γ, adiponectin, GLUT-4 expressions and glucose utilization. Further, EECV treatment decreased AMPK-α expression as compared with control and metformin treated cells. CONCLUSION: The present research findings confirmed that the EECV effectively modulates the lipid accumulation and differentiation in 3T3-L1 cells through AMPK-α mediated signalling pathway.


Subject(s)
Animals , Mice , Seaweed/chemistry , Plant Extracts/pharmacology , 3T3-L1 Cells/drug effects , Chlorella vulgaris/chemistry , Time Factors , Down-Regulation , Gene Expression , Cell Differentiation/drug effects , Up-Regulation , Cell Survival/drug effects , Cells, Cultured , Adipocytes/cytology , Adipocytes/drug effects , Adipocytes/metabolism , Reverse Transcriptase Polymerase Chain Reaction , 3T3-L1 Cells/physiology , PPAR gamma/analysis , PPAR gamma/drug effects , PPAR gamma/metabolism , Diabetes Mellitus, Type 2/metabolism , Adiponectin/analysis , Adiponectin/metabolism , Glucose Transporter Type 4/analysis , Glucose Transporter Type 4/drug effects , Glucose Transporter Type 4/metabolism , AMP-Activated Protein Kinases/analysis , AMP-Activated Protein Kinases/drug effects , AMP-Activated Protein Kinases/metabolism , Glucose/metabolism
20.
Acta Cir Bras ; 30(9): 617-23, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26465106

ABSTRACT

PURPOSE: To investigate the effect of metformin on renal tubular epithelial cell apoptosis and inflammation after kidney ischemia/ reperfusion in rats. METHODS: Eighteen SD rats were randomly divided into three groups: Sham (S), Ischemia/reperfusion (I/R), and Metformin (E). Before establishing the I/R model, group E was administered metformin for three days, while groups S and I/R were administered equal volumes of saline. After three days, a right nephrectomy was performed on all groups, after which the left kidneys of groups E and I/R rats were subjected to 45 min renal ischemia. Renal function, histology, and cell apoptosis were assessed. AMPK, pAMPK, COX-2, and Caspase 3 were also detected. RESULTS: Compared to I/R group, Caspase 3 and COX-2 levels were decreased in group E. COX-2, Caspase3 and pAMPK levels were higher in groups E and I/R than in group S. The pAMPK level of group E was higher than that of I/R group, while COX-2 and caspase 3 were lower in group E than they were in the other groups. There was no significant difference between E and I/R groups in AMPK levels. CONCLUSION: Metformin preconditioning attenuated the inflammation caused by ischemia/reperfusion and inhibited the apoptosis of renal tubular epithelial cells.


Subject(s)
Apoptosis/drug effects , Epithelial Cells/drug effects , Ischemic Preconditioning/methods , Kidney/blood supply , Kidney/drug effects , Metformin/pharmacology , Reperfusion Injury/prevention & control , AMP-Activated Protein Kinases/analysis , Animals , Blood Urea Nitrogen , Blotting, Western , Caspase 3/analysis , Creatinine/blood , Cyclooxygenase 2/analysis , Immunohistochemistry , Kidney/pathology , Male , Random Allocation , Rats, Sprague-Dawley , Reproducibility of Results , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...